Fulgent Genetics Adds Influenza A and B to All Covid-19 Tests
Fulgent Genetics says covid-19 and Influenza A/B will be run on a single nasal swab at no additional cost to patients.
Read MorePosted by Melanie Hamilton-Basich | Sep 4, 2020 | Company News, Covid 19 |
Fulgent Genetics says covid-19 and Influenza A/B will be run on a single nasal swab at no additional cost to patients.
Read MorePosted by Melanie Hamilton-Basich | Aug 29, 2020 | Cancer, Molecular Diagnostics |
Foundation Medicine’s FoundationOne Liquid CDx is a pan-tumor liquid biopsy test for patients with solid tumors.
Read MorePosted by Melanie Hamilton-Basich | Aug 28, 2020 | Company News, Covid 19 |
Fulgent Houston will focus on covid-19 testing initially, with capacity for 20,000 tests per day and the ability to expand as demand continues to increase.
Read MorePosted by Melanie Hamilton-Basich | Aug 25, 2020 | Covid 19 |
The P-Best covid-19 pooling test algorithm identified all positive subjects, including asymptomatic carriers, in a single round of testing.
Read MorePosted by Melanie Hamilton-Basich | Aug 21, 2020 | Cancer, Molecular Diagnostics |
The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from the new hematology-oncology portfolio.
Read More